Avastin Recalled Over Eye Infections - Physician's First Watch

media

Avastin (bevacizumab) unit dose syringes have been recalled after five intraocular infections were reported to the manufacturer. The cancer drug was used off-label to treat macular degeneration.
The syringes were sent to physicians' offices in Georgia, Louisiana, South Carolina, and Indiana beginning December 18, 2012.

LINK(S):

Manufacturer's news release (Free)